| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Hassan Fred is a Director at COCP, with reported holdings spanning 4 companies. Recent filings cover 5 purchases and 0 sales. Those positions are worth an estimated $1.9M at current prices.
Hassan Fred's largest disclosed position is in COCP as Director, worth about $1.9M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2023 | PGEN Precigen, Inc. | Director | Buy | 570,345 | $1.75 | $998,103.75 | +184.8% | -46.4% | -34.3% | |
| Dec 29, 2021 | BBIO Bridgebio Pharma, Inc. | Director | Buy | 19,300 | $14.17 | $273,390.29 | New | -23.5% | -46.7% | |
| Dec 1, 2016 | PGEN Precigen, Inc. | Director | Buy | 6,900 | $29.02 | $200,266.29 | New | - | - | |
| Aug 19, 2015 | AMGN Amgen Inc | Director | Buy | 3,010 | $166.63 | $501,562.10 | +526.2% | - | - |